Loading…
Employees: 6,158
Size Allmed Medical Products (002950.SZ) is a China Health Care company (Medical Specialties) with a market value of $798M, the 2769th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥8.40 on 6 Nov 2026.
Performance Over six months the shares fell 39.0%, against -7.3% for the median peer and -16.4% for the China market (cap-weighted) — lowest of 21 in its peer set.
Growth Revenue grew 13.9% over the last twelve months (peer median +9.1%); the operating margin is 8.1% (peer median 11.2%).
Valuation It trades at 1.6× enterprise value to sales against a peer median of 3.3× (5th cheapest of 21).
Capital Return on invested capital runs 1.0 points above its cost of capital (6.9% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥3.96B | CN¥3.66B | CN¥3.32B | CN¥2.74B | CN¥4.18B |
| Revenue growth | — | +10% | +21% | -35% | — |
| Gross profit | CN¥1.29B | CN¥974M | CN¥886M | CN¥672M | CN¥1.33B |
| EBITDA | n/a | CN¥808M | CN¥666M | CN¥410M | CN¥1.01B |
| Net income | CN¥221M | CN¥249M | CN¥369M | CN¥110M | CN¥407M |
| Free cash flow | -CN¥156M | CN¥463M | CN¥559M | CN¥140M | CN¥752M |
| Capital expenditure | CN¥465M | CN¥260M | CN¥157M | CN¥286M | CN¥398M |
| Total debt | CN¥1.44B | CN¥837M | CN¥684M | CN¥970M | CN¥1.33B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 002950.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -3.5% | -2.7% | 11th highest of 21 |
| 6-month return | -39.0% | -7.3% | lowest of 21 |
| Distance from 52-week high | -43.6% | -28.7% | 4th lowest of 21 |
| Revenue growth (TTM) | +13.9% | +9.1% | 10th highest of 21 |
| Operating margin | 8.1% | 11.2% | 8th lowest of 21 |
| EV / Sales | 1.6× | 3.3× | 5th cheapest of 21 |
| ROIC minus cost of capital | +1.0 pp | +0.1 pp | 10th highest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Allmed Medical Products 002950.SZ | China | $798M | -39% | +14% | 8% | 1.6× | n/a | n/a |
| Cofoe Medical Technology 1187.HK | Hong Kong | $798M | -27% | +40% | 10% | 0.9× | -8.0% | +6.6% |
| Standard Engineering Technology SETL.NS | India | $796M | +164% | +26% | 13% | 8.9× | n/a | n/a |
| Shanghai Aladdin Biochemical Technology 688179.SS | China | $806M | -25% | +39% | 26% | 6.8× | 21.1% | +24.2% |
| Shanghai INT Medical Instruments 1501.HK | Hong Kong | $784M | -25% | +35% | 21% | 4.1× | -2.1% | +23.5% |
| Varex Imaging VREX | United States | $783M | -10% | +5% | 8% | 1.2× | n/a | n/a |
| Maccura Biotechnology 300463.SZ | China | $814M | -14% | -1% | -4% | 2.5× | 9.2% | -10.2% |
| BMC Medical 301367.SZ | China | $780M | -13% | +37% | 17% | 2.0× | 0.1% | +15.6% |
| Advanced Medical Solutions AMS.L | United Kingdom | $824M | +14% | +6% | 12% | 2.9× | 19.6% | +21.4% |
| Hangzhou Biotest Biotech 688767.SS | China | $824M | +5% | -4% | 3% | 9.7× | n/a | n/a |
| OrthoPediatrics KIDS | United States | $829M | +78% | +16% | -8% | 3.4× | n/a | n/a |
| InMode INMD | United States | $767M | -5% | -7% | 18% | 0.7× | -10.5% | +12.4% |
| Beijing Aerospace Changfeng 600855.SS | China | $832M | -35% | -10% | -19% | 5.1× | n/a | n/a |
| Cytek Biosciences CTKB | United States | $758M | +26% | +5% | -22% | 2.6× | n/a | n/a |
| Doctorglasses Chain 300622.SZ | China | $757M | -10% | +6% | 14% | 3.3× | -2.4% | +15.7% |
| Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZ | China | $750M | +177% | -14% | 3% | 11.1× | 33.5% | -0.6% |
| Shenzhen Lifotronic Technology 688389.SS | China | $749M | -11% | +14% | 13% | 3.3× | 13.5% | +13.3% |
| Zylox-Tonbridge Medical Technology 2190.HK | Hong Kong | $851M | -13% | +39% | 25% | 4.0× | 5.5% | +105.8% |
| Beta Bionics BBNX | United States | $854M | +63% | +44% | -73% | 4.9× | n/a | n/a |
| Menicon 7780.T | Japan | $854M | +12% | +5% | 9% | 1.4× | n/a | n/a |
| Jiang Xi Sanxin Medtec 300453.SZ | China | $741M | -5% | +12% | 18% | 2.8× | -2.1% | +11.8% |